Williams Douglas E
SEC-identified person · CIK 1184847 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Camp4 Therapeutics Corp CAMP | Director | filed 2025 - 2026 |
| Eliem Therapeutics, Inc. ELYM | Director | filed 2024 - 2026 |
| Sana Biotechnology, Inc. SANA | EVP & President, R&D | filed 2023 - 2024 |
| Codiak Biosciences, Inc. CDAK | Director · See Remarks | filed 2020 - 2023 |
| Ovid Therapeutics Inc. OVID | Director | filed 2017 - 2021 |
| Panacea Acquisition Corp. II PANA | Director | filed 2021 - 2021 |
| Ironwood Pharmaceuticals INC IRWD | Director | filed 2014 - 2019 |
| Regulus Therapeutics Inc. RGLS | Director | filed 2012 - 2016 |
| Biogen INC. BIIB | EVP Research & Development | filed 2011 - 2015 |
| Oncothyreon Inc. ONTY | Director | filed 2009 - 2013 |
| Array Biopharma INC ARRY | Director | filed 2007 - 2010 |
| Zymogenetics INC ZGEN | Director · President and CSO | filed 2006 - 2010 |
| Anadys Pharmaceuticals INC ANDS | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.